Risk factors for HIV-1 seroconversion among injection drug users: A case- control study

D.D. Chitwood, D.K. Griffin, M. Comerford, J.B. Page, E.J. Trapido, S. Lai and C.B. McCoy

American Journal of Public Health, 1995, vol. 85, issue 11, 1538-1542

Abstract: Objectives. A nested case-control study was conducted in Miami, Fla, to determine risk factors associated with human immunodeficiency virus type 1 (HIV-1) seroconversion among injection drug users. Methods. The study identified 21 incident cases of HIV-1 infection and 76 unmatched controls from two longitudinal cohorts of injection drug users. One cohort consisted of individuals who originally had been recruited from treatment centers; a second cohort was recruited from the 'street.' Logistic regression analyses that adjusted for age, gender, and race were performed. Results. The final model determined that the primary independent risk factor that best explained the risk for seroconversion was sharing injection equipment in the year prior to conversion; a marginal risk factor was presence of sexually transmitted disease during this same period. Conclusions. Both an injection component and a sexual component play a role in seroconversion among injection drug users, although the injection component is much stronger.

Date: 1995
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:1995:85:11:1538-1542_8

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().